EE04094B1 - N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks - Google Patents

N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks

Info

Publication number
EE04094B1
EE04094B1 EEP199900279A EEP9900279A EE04094B1 EE 04094 B1 EE04094 B1 EE 04094B1 EE P199900279 A EEP199900279 A EE P199900279A EE P9900279 A EEP9900279 A EE P9900279A EE 04094 B1 EE04094 B1 EE 04094B1
Authority
EE
Estonia
Prior art keywords
irds
cyclopropylmethoxy
ards
treatment
difluoromethoxy
Prior art date
Application number
EEP199900279A
Other languages
English (en)
Estonian (et)
Inventor
Germann Paul-Georg
Kilian Ulrich
Beume Rolf
Amschler Hermann
Kr�ger Uwe
H�fner Dietrich
Eistetter Klaus
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9900279A publication Critical patent/EE9900279A/xx
Publication of EE04094B1 publication Critical patent/EE04094B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP199900279A 1997-02-17 1998-02-14 N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks EE04094B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19
PCT/EP1998/000847 WO1998035683A1 (en) 1997-02-17 1998-02-14 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant

Publications (2)

Publication Number Publication Date
EE9900279A EE9900279A (et) 2000-02-15
EE04094B1 true EE04094B1 (et) 2003-08-15

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900279A EE04094B1 (et) 1997-02-17 1998-02-14 N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks

Country Status (25)

Country Link
US (2) US6436970B1 (cs)
EP (1) EP0977577B1 (cs)
JP (1) JP4763104B2 (cs)
KR (1) KR100640025B1 (cs)
CN (1) CN1123345C (cs)
AT (1) ATE336254T1 (cs)
AU (1) AU734122B2 (cs)
BR (1) BR9807399B1 (cs)
CA (1) CA2276429C (cs)
CZ (1) CZ293871B6 (cs)
DE (1) DE69835594T2 (cs)
DK (1) DK0977577T3 (cs)
EA (1) EA001758B1 (cs)
EE (1) EE04094B1 (cs)
ES (1) ES2271990T3 (cs)
HU (1) HU227520B1 (cs)
IL (1) IL130658A (cs)
NO (1) NO323594B1 (cs)
NZ (1) NZ336569A (cs)
PL (1) PL190775B1 (cs)
PT (1) PT977577E (cs)
SI (1) SI0977577T1 (cs)
TR (1) TR199901772T2 (cs)
UA (1) UA50808C2 (cs)
WO (1) WO1998035683A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199901772T2 (cs) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
JP2001081031A (ja) * 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
EP1289961A1 (en) * 2000-05-25 2003-03-12 Merck Frosst Canada & Co. Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
EP1397359B1 (en) 2001-05-24 2005-08-31 Merck Frosst Canada & Co. 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
US20060142308A1 (en) * 2002-11-27 2006-06-29 Atlanta Pharma Ag Synergistic combination comprising roflumilast and formoterol
RS51082B (sr) * 2002-11-27 2010-10-31 Nycomed Gmbh. Sinergistička kombinacija koja uključuje roflumilas i (r.r.) -formoterol
US7470791B2 (en) 2003-03-10 2008-12-30 Nycomed Gmbh Process for the preparation of roflumilast
CA2529007C (en) * 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
EP1781323B1 (en) 2004-08-06 2010-02-17 Nycomed GmbH Composition comprising a pulmonary surfactant and a tnf-derived peptide
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
AU2007334541A1 (en) * 2006-12-13 2008-06-26 Gilead Sciences, Inc. Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (AISTM's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
NZ208107A (en) * 1983-05-11 1986-12-05 Byk Gulden Lomberg Chem Fab 6-aryl-3(2h)-pyridazinones and pharmaceutical compositions
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
CN1046939C (zh) * 1993-07-02 1999-12-01 比克·古尔顿·劳姆贝尔格化学公司 氟烷氧基取代的苯甲酰胺类及其制备方法和应用
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
TR199901772T2 (cs) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
AU7132600A (en) * 1999-06-29 2001-01-31 Ltech Corporation Chemical film cleaning and drying

Also Published As

Publication number Publication date
DE69835594T2 (de) 2007-08-16
CA2276429A1 (en) 1998-08-20
AU6497398A (en) 1998-09-08
KR100640025B1 (ko) 2006-10-31
EA001758B1 (ru) 2001-08-27
CZ291499A3 (cs) 2000-02-16
NO323594B1 (no) 2007-06-11
BR9807399A (pt) 2000-03-14
NO993875L (no) 1999-08-11
CN1248169A (zh) 2000-03-22
HU227520B1 (hu) 2011-07-28
PL335134A1 (en) 2000-04-10
CZ293871B6 (cs) 2004-08-18
JP2001512452A (ja) 2001-08-21
NO993875D0 (no) 1999-08-11
US6998410B2 (en) 2006-02-14
CN1123345C (zh) 2003-10-08
CA2276429C (en) 2007-06-19
IL130658A0 (en) 2000-06-01
HK1026145A1 (en) 2000-12-08
DE69835594D1 (de) 2006-09-28
ES2271990T3 (es) 2007-04-16
HUP0001043A2 (hu) 2000-09-28
DK0977577T3 (da) 2006-12-18
EE9900279A (et) 2000-02-15
KR20000071112A (ko) 2000-11-25
EP0977577B1 (en) 2006-08-16
IL130658A (en) 2004-07-25
AU734122B2 (en) 2001-06-07
UA50808C2 (uk) 2002-11-15
WO1998035683A1 (en) 1998-08-20
US6436970B1 (en) 2002-08-20
JP4763104B2 (ja) 2011-08-31
US20020132835A1 (en) 2002-09-19
SI0977577T1 (sl) 2007-02-28
HUP0001043A3 (en) 2002-12-28
TR199901772T2 (cs) 1999-09-21
NZ336569A (en) 2001-04-27
EP0977577A1 (en) 2000-02-09
PT977577E (pt) 2007-02-28
BR9807399B1 (pt) 2011-04-19
EA199900645A1 (ru) 2000-04-24
ATE336254T1 (de) 2006-09-15
PL190775B1 (pl) 2006-01-31

Similar Documents

Publication Publication Date Title
EE9900279A (et) N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
NO20012787D0 (no) GLP-1 analoger
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
IL152554A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII
ES2081716T3 (es) Procedimiento para la fabricacion de resina de organopolisiloxano.
DK0494405T3 (da) Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
FI842588A7 (fi) Suun, nenän ja/tai nielun limakalvoihin vaikuttavat lääkeaineet, joiden perustana ovat hepariini ja tensidit.
DE59308848D1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
ID28119A (id) Pati yang dimodifikasi stabil-garam
DE69332654D1 (de) Fragmente eines oberflächenaktiven lungenproteins
BR9916489A (pt) Agente aromatizante tipo jogo
ES2176330T3 (es) Compuestos y composiciones para administracion por inhalacion oral o insuflacion.
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
RU97107034A (ru) Способ лечения синдрома сухого глаза
SE8903764D0 (sv) Lung protection agents
ES2188189T3 (es) Composiciones que comprenden derivados de acido fenil-amino-tiofeno-acetico para el tratamiento del sindrome de angustia respiratoria aguda o de adultos (ards) y del sindrome de angustia respiratoria de niños (irds).
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)
ATE235238T1 (de) Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
ATE322541T1 (de) Pestivirus mutanten und dessen enthaltende impfstoffe
DK0458536T3 (da) Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner